dabigatran has been researched along with fumarates in 2 studies
Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (fumarates) | Trials (fumarates) | Recent Studies (post-2010) (fumarates) |
---|---|---|---|---|---|
3,887 | 261 | 3,490 | 4,655 | 342 | 1,823 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Livio, F | 1 |
Anderson, T; Chang, CH; Choudhry, NK; Donohue, JM; Gellad, WF; Guclu, H; Huskamp, HA; Junker, SP; Lo-Ciganic, WH; Richards-Shubik, S; Zhang, R | 1 |
1 review(s) available for dabigatran and fumarates
Article | Year |
---|---|
[Pharmacovigilance update].
Topics: Adrenergic Uptake Inhibitors; Age Factors; Aged; Amides; Antihypertensive Agents; Atomoxetine Hydrochloride; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Drug-Related Side Effects and Adverse Reactions; Fibrinolytic Agents; Fumarates; Hemorrhage; Humans; Pharmacovigilance; Propylamines | 2013 |
1 other study(ies) available for dabigatran and fumarates
Article | Year |
---|---|
Influence of peer networks on physician adoption of new drugs.
Topics: Amides; Dabigatran; Drug Prescriptions; Drug Utilization; Female; Fumarates; Humans; Male; Medicaid; Medicare; Peer Group; Pennsylvania; Practice Patterns, Physicians'; Sitagliptin Phosphate; United States | 2018 |